# A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude

> **NCT01794078** · PHASE1 · COMPLETED · sponsor: **Robert J Noveck, M.D.** · enrollment: 92 (actual)

## Conditions studied

- Acute Mountain Sickness and Fatigue

## Interventions

- **DRUG:** Aminophylline 400 mg
- **DRUG:** Ambrisentan 5 mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01794078
- **Lead sponsor:** Robert J Noveck, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2015-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794078, "A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01794078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*